Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertram Pitt

Showing results (441-450 of 688) with videos related to

Pageof 69
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 29, 2018
Collagen biomarker bioprofiles predicting the antifibrotic response to eplerenone in myocardial infarction: findings from the REMINDER trialJoão Pedro Ferreira, António Barros, Bertram Pitt, et al.
JACC. Heart Failure|April 4, 2016
QRS Duration Is a Predictor of Adverse Outcomes in Heart Failure With Preserved Ejection FractionJacob Joseph, Brian C Claggett, Inder S Anand, et al.
JACC. Heart Failure|October 10, 2024
Undiagnosed Diabetes in Heart Failure With Preserved Ejection FractionJohn W Ostrominski, Mats C Højbjerg Lassen, Brian L Claggett, et al.
Diabetes, Obesity & Metabolism|October 4, 2022
Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist usePeter Rossing, Rajiv Agarwal, Stefan D Anker, et al.
Journal of Hypertension|October 5, 2019
Visit-to-visit blood pressure variation and outcomes in heart failure with reduced ejection fraction: findings from the Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms trialLuca Monzo, João Pedro Ferreira, Paula Abreu, et al.
Journal of the American College of Cardiology|July 13, 2010
Cardiovascular events during differing hypertension therapies in patients with diabetesMichael A Weber, George L Bakris, Kenneth Jamerson, et al.
International Journal of Cardiology|January 13, 2009
Oral potassium supplement use and outcomes in chronic heart failure: a propensity-matched studyO James Ekundayo, Chris Adamopoulos, Mustafa I Ahmed, et al.
International Journal of Cardiology|June 9, 2009
Mild hyperkalemia and outcomes in chronic heart failure: a propensity matched studyMustafa I Ahmed, O James Ekundayo, Marjan Mujib, et al.
Journal of Cardiac Failure|May 31, 2022
Prognostic Impact of Cardiovascular Versus Noncardiovascular Hospitalizations in Heart Failure With Preserved Ejection Fraction: Insights From TOPCATEbrahim Barkoudah, Brian L Claggett, Eldrin F Lewis, et al.
Journal of the American College of Cardiology|May 20, 2021
Finerenone Reduces New-Onset Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 DiabetesGerasimos Filippatos, George L Bakris, Bertram Pitt, et al.
Pageof 69

Showing results (441-450 of 688) with videos related to

Sort By:
Pageof 69
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 29, 2018
Collagen biomarker bioprofiles predicting the antifibrotic response to eplerenone in myocardial infarction: findings from the REMINDER trialJoão Pedro Ferreira, António Barros, Bertram Pitt, et al.
JACC. Heart Failure|April 4, 2016
QRS Duration Is a Predictor of Adverse Outcomes in Heart Failure With Preserved Ejection FractionJacob Joseph, Brian C Claggett, Inder S Anand, et al.
JACC. Heart Failure|October 10, 2024
Undiagnosed Diabetes in Heart Failure With Preserved Ejection FractionJohn W Ostrominski, Mats C Højbjerg Lassen, Brian L Claggett, et al.
Diabetes, Obesity & Metabolism|October 4, 2022
Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist usePeter Rossing, Rajiv Agarwal, Stefan D Anker, et al.
Journal of Hypertension|October 5, 2019
Visit-to-visit blood pressure variation and outcomes in heart failure with reduced ejection fraction: findings from the Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms trialLuca Monzo, João Pedro Ferreira, Paula Abreu, et al.
Journal of the American College of Cardiology|July 13, 2010
Cardiovascular events during differing hypertension therapies in patients with diabetesMichael A Weber, George L Bakris, Kenneth Jamerson, et al.
International Journal of Cardiology|January 13, 2009
Oral potassium supplement use and outcomes in chronic heart failure: a propensity-matched studyO James Ekundayo, Chris Adamopoulos, Mustafa I Ahmed, et al.
International Journal of Cardiology|June 9, 2009
Mild hyperkalemia and outcomes in chronic heart failure: a propensity matched studyMustafa I Ahmed, O James Ekundayo, Marjan Mujib, et al.
Journal of Cardiac Failure|May 31, 2022
Prognostic Impact of Cardiovascular Versus Noncardiovascular Hospitalizations in Heart Failure With Preserved Ejection Fraction: Insights From TOPCATEbrahim Barkoudah, Brian L Claggett, Eldrin F Lewis, et al.
Journal of the American College of Cardiology|May 20, 2021
Finerenone Reduces New-Onset Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 DiabetesGerasimos Filippatos, George L Bakris, Bertram Pitt, et al.
Pageof 69